| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/2005 | CA2536146A1 Splice variants of erbb ligands, compositions and uses thereof |
| 02/24/2005 | CA2535984A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 02/24/2005 | CA2535863A1 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | CA2535805A1 Multifactorial assay for cancer detection |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535451A1 Method of treating viral infections |
| 02/24/2005 | CA2535261A1 Prion-specific peptide reagents |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | CA2534895A1 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | CA2534676A1 Orally administered small peptides synergize statin activity |
| 02/24/2005 | CA2534474A1 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | CA2534436A1 Antagonistic analogs of gh-rh (2003) |
| 02/24/2005 | CA2534215A1 Methods of therapy for chronic lymphocytic leukemia |
| 02/24/2005 | CA2534197A1 Use of a vegf antagonist in combination with radiation therapy |
| 02/24/2005 | CA2534028A1 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 02/24/2005 | CA2533641A1 Lactoperoxidase as an osteogenesis promoter |
| 02/24/2005 | CA2532027A1 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | CA2531253A1 Sir2 regulation |
| 02/24/2005 | CA2530803A1 A novel antiproliferative factor and methods of use |
| 02/24/2005 | CA2529307A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/24/2005 | CA2528514A1 Improved recombinant human interferon-beta-1b polypeptides |
| 02/24/2005 | CA2525670A1 Hair regenerator |
| 02/24/2005 | CA2525647A1 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | CA2516425A1 Rna interference compositions and methods |
| 02/23/2005 | EP1508620A1 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 02/23/2005 | EP1508619A1 Novel promoter |
| 02/23/2005 | EP1508615A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/23/2005 | EP1508575A1 Novel leptin antagonist |
| 02/23/2005 | EP1508338A1 Mycobacterial protein antigens for cancer therapy and vaccination |
| 02/23/2005 | EP1508337A2 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 02/23/2005 | EP1508336A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 02/23/2005 | EP1508047A2 Method for identifying immunoreactive peptides |
| 02/23/2005 | EP1508043A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
| 02/23/2005 | EP1507860A2 Dynamic action reference tools |
| 02/23/2005 | EP1507856A1 Regulation of human serine/threonine kinase |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507853A1 Palliative treatment for gluten intolerance |
| 02/23/2005 | EP1507850A1 A method for generating antigen-presenting cells |
| 02/23/2005 | EP1507826A2 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/23/2005 | EP1507800A1 Use of monocarboxylate transporter protein for thyroid hormone transport |
| 02/23/2005 | EP1507799A2 Novel cyclic peptides and use thereof as anti-microbial agents |
| 02/23/2005 | EP1507798A1 Export and modification of (poly)peptides in the lantibiotic way |
| 02/23/2005 | EP1507797A2 Inhibitors of proteins from the rho-gef family |
| 02/23/2005 | EP1507796A1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/23/2005 | EP1507794A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/23/2005 | EP1507793A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 02/23/2005 | EP1507791A2 Antisense antiviral agent and method for treating ssrna viral infection |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |
| 02/23/2005 | EP1507787A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
| 02/23/2005 | EP1507555A2 Induction of antigen specific immunologic tolerance |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507551A2 The functional role and potential therapeutic use of pacap, vip and maxadilan in relation to adult neural stem or progenitor cells |
| 02/23/2005 | EP1507550A1 Suicide tetramers comprising mhc class i and uses thereof |
| 02/23/2005 | EP1507549A2 Drug therapy for celiac sprue |
| 02/23/2005 | EP1507547A2 Peptides for regulation of urokinase (upa) and tissue type (tpa) plasminogen activator and method of optimizing therapeutic efficacy |
| 02/23/2005 | EP1507546A2 Methods of using 22417, a novel human aminoprotease family member |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1507516A1 Co-grinding process for the preparation of a ternary composition |
| 02/23/2005 | EP1175224B1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1035870B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 02/23/2005 | EP0941114B1 Use of glp-1 peptides |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585649A Method of improving wound healing |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/23/2005 | CN1585604A Compositions for appetite control and related methods |
| 02/23/2005 | CN1584031A Preparation of effective expressed human DNA enzyme repression factors and their uses in medicines against oxidation and its use against generation of blood vessels |
| 02/23/2005 | CN1584030A Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 02/23/2005 | CN1584029A Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 02/23/2005 | CN1584020A Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 02/23/2005 | CN1583794A Targeted anti-tumour fused protein containing adenovirus E40rf4 protein |
| 02/23/2005 | CN1583791A Extraction and purification of sheep skin growth factor as medicine for inflammatory enteropathy |
| 02/23/2005 | CN1583787A Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 02/23/2005 | CN1583785A Neutral and variable sites of cytomembrane protein M2 of influenza virus and their use |
| 02/23/2005 | CN1583170A Medicine for human lysozyme against virus and drug-fast bacteria and its preparation |
| 02/23/2005 | CN1583169A Use of human lysozyme in preparation of medicine for hemorrhoid |
| 02/23/2005 | CN1583168A Use of human lysozyme in preparation of medicine for unhealed ulceration by wound inflammation |
| 02/23/2005 | CN1583167A Use of recommbined human lysozyme in preparation of medicine for bronchial asthma |
| 02/23/2005 | CN1583166A Chinese forest frog bactericidal peptide spray agent and its preparation |
| 02/23/2005 | CN1583165A Gel gent of Chiense forest frog bactericidal peptide |
| 02/23/2005 | CN1583164A Preparing procedure of transfer factor for intravenous injection |
| 02/23/2005 | CN1583163A Preparing procedure for enteric soluble capsules of transfer factor |
| 02/23/2005 | CN1583162A Injection of donkey hide gelatin and its preparation |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190445C Process for producing functional silk fibroin and utilization of the same |
| 02/23/2005 | CN1190240C Composite transplant containing concanavalin A and its preparation and application |
| 02/23/2005 | CN1190198C Modulation of TH1/TH2 cytokine expression by Ribavirin and Ribavirin analogs activated T-lymphocytes |
| 02/22/2005 | US6858716 Drosophila recombination-associated protein and methods for use |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |